Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rivastigmine Patch in Veterans With Cognitive Impairment Following TBI

NCT01670526 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT01670526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01670526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rivastigmine Patch in Veterans With Cognitive Impairment Following TBI
Lead sponsor
VA Office of Research and Development
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2012
Completion date
September 30, 2017
Enrollment
94 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive impairment, traumatic brain injury